Swoop® Portable MR Imaging® System vs Viz ANEURYSM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Viz.ai

AI Verdict

Tool A is a portable MRI imaging system that generates diagnostic images for a broad range of neurological conditions, with AI assisting in image reconstruction. In contrast, Tool B is an AI-powered software solution that analyzes existing CT angiograms specifically to detect cerebral aneurysms and facilitate care coordination. While both leverage AI for neurological clinical decision support, they serve distinct functions: one provides imaging hardware, and the other analyzes pre-existing imaging data.

Choose Swoop® Portable MR Imaging® System if…

Choose Swoop Portable MR Imaging System if you require immediate, point-of-care brain imaging for patients who cannot easily be transported to a traditional MRI suite, such as those in the ICU, emergency department, or specialized clinics. This system is ideal for bringing diagnostic MRI capabilities directly to the patient's bedside, enabling rapid assessment and clinical decision-making in diverse settings.

View Swoop® Portable MR Imaging® System →

Choose Viz ANEURYSM if…

Choose Viz ANEURYSM if your priority is to rapidly detect and streamline the care coordination for suspected cerebral aneurysms identified on CT angiograms. This AI-powered solution is best suited for enhancing neurovascular workflows by providing automated detection, AI-enhanced 3D imaging, and real-time communication tools to facilitate timely patient management and referral processes.

View Viz ANEURYSM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Swoop® Portable MR Imaging® System Viz ANEURYSM
Pricing Enterprise Contact for pricing
Deployment Hybrid Cloud-based; Standalone application; Mobile software module
FDA Status Cleared AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Swoop® Portable MR Imaging® System

Tool A's 'intuitive iPad-based interface' and 'point-of-care' design suggest a simpler and more direct user experience for image acquisition, making it accessible to a broader range of clinicians. Its portability further enhances ease of deployment in diverse clinical settings. Tool B focuses more on optimizing complex neurovascular workflows and communication.

Clinical Value

Swoop® Portable MR Imaging® System

Tool A offers broader clinical utility by making MRI accessible at the point of care for various neurological conditions, potentially transforming diagnostic pathways in underserved areas or critical care settings. While Tool B provides critical value for a specific, time-sensitive condition, Swoop's ability to bring a powerful diagnostic modality directly to the patient represents a more fundamental shift in care delivery and access.

Pricing & Value

Tie

Both tools employ an enterprise, contact-for-pricing model with no public transparency or free trial options. Without specific cost details or comparative return on investment (ROI) studies, it is impossible to determine which offers better value.

Enterprise Readiness

Swoop® Portable MR Imaging® System

Both tools are FDA-cleared and HIPAA compliant, offering essential enterprise-level features. However, Tool A's documented '200+ systems deployed globally' and its hybrid deployment model with DICOM compatibility and remote access demonstrate a more extensive proven track record and robust integration capabilities for diverse enterprise environments.

Innovation

Swoop® Portable MR Imaging® System

Tool A represents a more significant foundational innovation by creating the 'world's first and only FDA-cleared portable MRI,' fundamentally changing how and where MRI can be performed. While Tool B's AI for aneurysm detection is highly advanced and impactful, it builds upon existing imaging modalities, whereas Swoop introduces a new category of MRI accessibility.

Support & Docs

Tie

Both Hyperfine and Viz.ai indicate offering comprehensive enterprise-level support, including customer success teams and training resources. Without more specific details on documentation depth, service level agreements, or tiered support structures for either product, it is not possible to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Swoop® Portable MR Imaging® System Viz ANEURYSM
Name Swoopu00ae Portable MR Imagingu00ae System Viz ANEURYSM
Company Hyperfine Viz.ai
Description The Swoopu00ae Portable MR Imagingu00ae System is the world's first and only FDA-cleared portable MRI, enabling point-of-care brain imaging in diverse clinical settings. Viz ANEURYSM is an FDA-cleared AI-powered solution by Viz.ai that auto-detects suspected cerebral aneurysms in CT angiograms (CTAs), streamlining neurovascular care coordination and facilitating timely patient management.
Key Features Portability and compact design, Low power consumption (standard wall outlet), Intuitive iPad-based interface, AI-powered image reconstruction, Rapid scan times, Point-of-care imaging capabilities, DICOM compatibility for PACS integration, Remote access for tele-radiology Auto-detection of suspected cerebral aneurysms in CTAs, AI-enhanced 3D imaging (Viz 3D CTA), Interactive tools for neurovascular assessment, Streamlined workflow and automated 3D processing, Real-time notification to appropriate care providers, HIPAA-compliant secure messaging for care team coordination, One-click referral activation for follow-up, High sensitivity and specificity for aneurysm detection (e.g., u2265 4mm aneurysms)

Videos

Demos, reviews, and walkthroughs featuring Swoop® Portable MR Imaging® System and Viz ANEURYSM.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Swoop Portable MR Imaging System is an FDA-cleared portable MRI designed for point-of-care brain imaging in diverse clinical settings. Viz ANEURYSM is an FDA-cleared AI-powered solution that auto-detects suspected cerebral aneurysms in CT angiograms (CTAs) to streamline neurovascular care coordination.
The Swoop system provides actual MR imaging of the brain, utilizing AI for image reconstruction. Viz ANEURYSM analyzes existing CT angiograms (CTAs) to detect suspected cerebral aneurysms and offers AI-enhanced 3D imaging.
Swoop uses AI for image reconstruction to achieve rapid scan times. Viz ANEURYSM leverages AI for the auto-detection of suspected cerebral aneurysms in CTAs and for AI-enhanced 3D imaging.
Swoop is designed for general point-of-care brain imaging across various specialties such as Emergency Medicine, Neurology, and ICUs. Viz ANEURYSM specifically targets the detection of suspected cerebral aneurysms and the coordination of neurovascular care, including real-time notifications and one-click referral activation.
Swoop offers DICOM compatibility for PACS integration and remote access for tele-radiology. Viz ANEURYSM provides real-time notification to appropriate care providers, HIPAA-compliant secure messaging for care team coordination, and one-click referral activation, indicating integration with communication and referral workflows.

Backers

Who funded each tool's parent company.

Viz ANEURYSM

AI Tool Finder
AI-powered search. Results may not be comprehensive.